Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03090165
Title Ribociclib and Bicalutamide in AR+ TNBC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ruth O'Regan, M.D.

triple-receptor negative breast cancer


Bicalutamide + Ribociclib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Recruiting Chicago Illinois 60612 United States Details
Michigan State University Completed Lansing Michigan 48910 United States Details
Rutgers Cancer Institute of New Jersey Completed New Brunswick New Jersey 08903 United States Details
University of Rochester Medical Center Recruiting Rochester New York 14642 United States Details
Penn State Cancer Institute Completed Hershey Pennsylvania 17033 United States Details
University of Wisconsin Recruiting Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from for the field